These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization of the Han:SPRD rat model for hereditary polycystic kidney disease. Schäfer K; Gretz N; Bader M; Oberbäumer I; Eckardt KU; Kriz W; Bachmann S Kidney Int; 1994 Jul; 46(1):134-52. PubMed ID: 7933831 [TBL] [Abstract][Full Text] [Related]
3. The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease. Lager DJ; Qian Q; Bengal RJ; Ishibashi M; Torres VE Kidney Int; 2001 Jan; 59(1):126-36. PubMed ID: 11135065 [TBL] [Abstract][Full Text] [Related]
4. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats. Cowley BD; Ricardo SD; Nagao S; Diamond JR Kidney Int; 2001 Dec; 60(6):2087-96. PubMed ID: 11737583 [TBL] [Abstract][Full Text] [Related]
5. Azotemia and extrarenal manifestations in old female Han:SPRD (cy/+) rats. Kränzlin B; Schieren G; Gretz N Kidney Int; 1997 Apr; 51(4):1160-9. PubMed ID: 9083282 [TBL] [Abstract][Full Text] [Related]
6. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease. Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334 [TBL] [Abstract][Full Text] [Related]
7. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats. Cowley BD; Rupp JC; Muessel MJ; Gattone VH Am J Kidney Dis; 1997 Feb; 29(2):265-72. PubMed ID: 9016899 [TBL] [Abstract][Full Text] [Related]
8. Modification of disease progression in rats with inherited polycystic kidney disease. Cowley BD; Grantham JJ; Muessel MJ; Kraybill AL; Gattone VH Am J Kidney Dis; 1996 Jun; 27(6):865-79. PubMed ID: 8651252 [TBL] [Abstract][Full Text] [Related]
9. CTGF Is Expressed During Cystic Remodeling in the PKD/Mhm (cy/+) Rat Model for Autosomal-Dominant Polycystic Kidney Disease (ADPKD). Gauer S; Holzmann Y; Kränzlin B; Hoffmann SC; Gretz N; Hauser IA; Goppelt-Struebe M; Geiger H; Obermüller N J Histochem Cytochem; 2017 Dec; 65(12):743-755. PubMed ID: 29058957 [TBL] [Abstract][Full Text] [Related]
10. Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease. Raman A; Reif GA; Dai Y; Khanna A; Li X; Astleford L; Parnell SC; Calvet JP; Wallace DP J Am Soc Nephrol; 2017 Sep; 28(9):2708-2719. PubMed ID: 28522687 [TBL] [Abstract][Full Text] [Related]
11. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease]. Banković-Calić N; Ogbori MR; Nicman E Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002 [TBL] [Abstract][Full Text] [Related]
12. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease. Pey R; Bach J; Schieren G; Gretz N; Hafner M In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866 [TBL] [Abstract][Full Text] [Related]
13. The effect of paclitaxel on the progression of polycystic kidney disease in rodents. Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221 [TBL] [Abstract][Full Text] [Related]
14. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease. Gattone VH; Siqueira TM; Powell CR; Trambaugh CM; Lingeman JE; Shalhav AL Exp Biol Med (Maywood); 2008 Aug; 233(8):952-7. PubMed ID: 18480417 [TBL] [Abstract][Full Text] [Related]
15. Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease. Ramasubbu K; Gretz N; Bachmann S J Am Soc Nephrol; 1998 Jun; 9(6):937-45. PubMed ID: 9621276 [TBL] [Abstract][Full Text] [Related]
16. Differentiation and cell polarity during renal cyst formation in the Han:SPRD (cy/+) rat, a model for ADPKD. Obermüller N; Gretz N; Kriz W; van der Woude FJ; Reilly RF; Murer H; Biber J; Witzgall R Am J Physiol; 1997 Sep; 273(3 Pt 2):F357-71. PubMed ID: 9321908 [TBL] [Abstract][Full Text] [Related]
17. Focal overexpression of collagen IV characterizes the initiation of epithelial changes in polycystic kidney disease. Schäfer K; Bader M; Gretz N; Oberbäumer I; Bachmann S Exp Nephrol; 1994; 2(3):190-5. PubMed ID: 7922272 [TBL] [Abstract][Full Text] [Related]
18. A hereditary model of slowly progressive polycystic kidney disease in the mouse. Takahashi H; Calvet JP; Dittemore-Hoover D; Yoshida K; Grantham JJ; Gattone VH J Am Soc Nephrol; 1991 Jan; 1(7):980-9. PubMed ID: 1883968 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708 [TBL] [Abstract][Full Text] [Related]
20. The Han:SPRD rat is not a genetic model of human autosomal dominant polycystic kidney disease type 1. Nauta J; Goedbloed MA; Luider TM; Hoogeveen AT; van den Ouweland AM; Halley DJ Lab Anim; 1997 Jul; 31(3):241-7. PubMed ID: 9230505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]